Skip to content

ABOS - Acumen Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Acumen Pharmaceuticals Inc

ABOS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ABOSAcumen Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.60
52-wk low: $1.21
Prev close: $2.43
Mkt cap: $227.8M
Beta: 0.33
P/S: 538.8x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$12.9M

JS
Jim Simons
Q2 2026 13F
$1.8M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 15.4% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $228M

Valuation

P/S538.78
P/B3.46

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ABOS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $227.80M
Beta: 0.33

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

3.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-120.5%

$1.7M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$162K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ABOS

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.45-15.4%

-$0.39 expected

Next report

What the street expects next

EPS expected

-$0.38

-$0.49 to -$0.24

Revenue expected

$0.00

5 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

+0.03

Change in 30 days

-120.5%

ROA-45.8%

Growth

Beta0.33